Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosis.
In conclusion, RASSF2 gene is differently methylated in luminal and non-luminal tumors and is a promising suppressor gene with clinical involvement in breast cancer.
PMID: 26284587 [PubMed - as supplied by publisher]
Source: Oncotarget - Category: Cancer & Oncology Tags: Oncotarget Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Genetics | HER2 | Liechtenstein Health | Statistics | Study